These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7365656)

  • 1. Electrocoagulation induced immunity--an explanation for regression of neuroblastoma.
    Ziegler MM; Vega A; Koop CE
    J Pediatr Surg; 1980 Feb; 15(1):34-7. PubMed ID: 7365656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The liver and immunoregulation of neuroblastoma growth.
    Ziegler MM; Vega A; Cooper A; Schlesinger H; Koop CE
    J Pediatr Surg; 1981 Aug; 16(4 Suppl 1):578-82. PubMed ID: 7277159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects following carbon dioxide laser excision on experimental neuroblastoma.
    McCormack CJ; Naim JO; Rogers DW; Ziegler MM; Hinshaw JR
    J Pediatr Surg; 1989 Feb; 24(2):201-3. PubMed ID: 2498503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host immunity.
    Coriell LL
    J Pediatr Surg; 1968 Feb; 3(1):124-32. PubMed ID: 5655559
    [No Abstract]   [Full Text] [Related]  

  • 5. The spontaneous regression of neuroblastoma. Experimental evidence for a natural host immunity.
    Bolande RP
    Pathol Annu; 1991; 26 Pt 2():187-99. PubMed ID: 1861885
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunity to tumor antigens: potential implications in human neuroblastoma.
    Bernstein I; Hellström KE; Wright PW
    J Natl Cancer Inst; 1976 Sep; 57(3):711-5. PubMed ID: 135846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous regression of neuroblastoma.
    Evans AE; Gerson J; Schnaufer L
    Natl Cancer Inst Monogr; 1976 Nov; 44():49-54. PubMed ID: 1030781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of optimal therapy for neuroblastoma: a study of the immunomodulatory effects of surgery and irradiation in the murine C1300 neuroblastoma model.
    Topalian SL; Ziegler MM
    J Surg Oncol; 1987 Feb; 34(2):120-7. PubMed ID: 2949117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implications of immune reactions to neuroblastoma.
    Bill AH
    Surgery; 1969 Aug; 66(2):415-8. PubMed ID: 5797230
    [No Abstract]   [Full Text] [Related]  

  • 10. Rational selection of adjuvant chemotherapy after cytoreduction surgery for murine neuroblastoma.
    Naito H; Ziegler MM; Tsou KC
    Cancer Res; 1985 Aug; 45(8):3554-60. PubMed ID: 4016735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma.
    Ohashi K; Kobayashi G; Fang S; Zhu X; Antonia SJ; Krieg AM; Sandler AD
    J Pediatr Surg; 2006 Aug; 41(8):1361-8. PubMed ID: 16863838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12.
    Davidoff AM; Kimbrough SA; Ng CY; Shochat SJ; Vanin EF
    J Pediatr Surg; 1999 May; 34(5):902-6; discussion 906-7. PubMed ID: 10359203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma and nutritional support: influence on the host-tumor relationship.
    Ziegler MM; Kirby J; McCarrick JW; Ikeda CB; Dasher J
    J Pediatr Surg; 1986 Mar; 21(3):236-9. PubMed ID: 3958885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma.
    Mao Y; Eissler N; Blanc KL; Johnsen JI; Kogner P; Kiessling R
    Clin Cancer Res; 2016 Aug; 22(15):3849-59. PubMed ID: 26957560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connatal localized neuroblastoma. The case to delay treatment.
    Kerbl R; Urban CE; Lackner H; Höfler G; Ambros IM; Ratschek M; Ambros PF
    Cancer; 1996 Apr; 77(7):1395-401. PubMed ID: 8608521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapeutic effect of tumor necrosis after cryosurgery, electrocoagulation, and ligation.
    Neel HB; Ritts RE
    J Surg Oncol; 1979; 11(1):45-52. PubMed ID: 431082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
    Hero B; Simon T; Spitz R; Ernestus K; Gnekow AK; Scheel-Walter HG; Schwabe D; Schilling FH; Benz-Bohm G; Berthold F
    J Clin Oncol; 2008 Mar; 26(9):1504-10. PubMed ID: 18349403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor immunogenicity--the prime determinant of the nutritional influence on the host-tumor relationship.
    McCarrick JW; Ikeda CB; Ziegler MM
    JPEN J Parenter Enteral Nutr; 1986; 10(1):21-8. PubMed ID: 3945043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to neuroblastomas and melanomas.
    Hellström KE; Hellström I
    Annu Rev Med; 1972; 23():19-38. PubMed ID: 4566479
    [No Abstract]   [Full Text] [Related]  

  • 20. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells.
    Salcedo R; Stauffer JK; Lincoln E; Back TC; Hixon JA; Hahn C; Shafer-Weaver K; Malyguine A; Kastelein R; Wigginton JM
    J Immunol; 2004 Dec; 173(12):7170-82. PubMed ID: 15585838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.